{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:17:44Z","timestamp":1792444664997,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12495-w","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:10:23Z","timestamp":1767492623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical analysis of Mycoplasma pneumoniae necrotizing pneumonia in children"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"10","key":"12495_CR1","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/ppul.27110","volume":"59","author":"G Ding","year":"2024","unstructured":"Ding G, Yang L, Xu C, Vinturache A, Zhang Y. Necrotizing pneumonia associated with macrolide-resistant Mycoplasma in a child. Pediatr Pulmonol. 2024;59(10):2679\u201380. https:\/\/doi.org\/10.1002\/ppul.27110.","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"12495_CR2","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/ppul.26593","volume":"58","author":"XQ Luo","year":"2023","unstructured":"Luo XQ, Luo J, Wang CJ, Luo ZX, Tian DY, Xie XH. Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective study. Pediatr Pulmonol. 2023;58(10):2815\u201322. https:\/\/doi.org\/10.1002\/ppul.26593.","journal-title":"Pediatr Pulmonol"},{"key":"12495_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.prrv.2024.02.003","volume":"52","author":"MH Teresinha","year":"2024","unstructured":"Teresinha MH, Bueno FG, Danezi PJ, de Oliveira EJ, Feij\u00f3 AC, Bush A. Necrotizing pneumonia in children: A review. Paediatr Respir Rev. 2024;52:51\u20137. https:\/\/doi.org\/10.1016\/j.prrv.2024.02.003.","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"12495_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.19871\/j.cnki.xfcrbzz.2024.01.015","volume":"9","author":"S Zhao","year":"2024","unstructured":"Zhao S, Chen Z, Qi S, et al. Diagnosis and treatment guidelines for Mycoplasma pneumoniae pneumonia in Children(2023 Edition). Emerg Infect Dis Electron J. 2024;9(1):73\u20139. https:\/\/doi.org\/10.19871\/j.cnki.xfcrbzz.2024.01.015.","journal-title":"Emerg Infect Dis Electron J"},{"issue":"12","key":"12495_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3760\/cma.j.cn101070-20210716-00833","volume":"37","author":"DW Shi","year":"2022","unstructured":"Shi DW, Li L, Zhao MM, et al. Analysis of drug resistance gene in Mycoplasma pneumoniae and 13 pathogens in Bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia. Chin J Appl Clin Pediatr. 2022;37(12):893\u20136. https:\/\/doi.org\/10.3760\/cma.j.cn101070-20210716-00833.","journal-title":"Chin J Appl Clin Pediatr"},{"key":"12495_CR6","doi-asserted-by":"publisher","unstructured":"Chen Y, Li L, Wang C, Zhang Y, Zhou Y. Necrotizing pneumonia in children: early recognition and management. J Clin Med. 2023;12(6). https:\/\/doi.org\/10.3390\/jcm12062256.","DOI":"10.3390\/jcm12062256"},{"key":"12495_CR7","doi-asserted-by":"publisher","unstructured":"Masters IB, Isles AF, Grimwood K. Necrotizing pneumonia: an emerging problem in children? Pneumonia (Nathan). 2017;9:11. https:\/\/doi.org\/10.1186\/s41479-017-0035-0.","DOI":"10.1186\/s41479-017-0035-0"},{"issue":"1","key":"12495_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12879-021-06469-x","volume":"21","author":"B Yang","year":"2021","unstructured":"Yang B, Zhang W, Gu W, et al. Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children. BMC Infect Dis. 2021;21(1):797. https:\/\/doi.org\/10.1186\/s12879-021-06469-x.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"12495_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3345\/cep.2022.01452","volume":"67","author":"K Yun","year":"2024","unstructured":"Yun K. Community-acquired pneumonia in children: updated perspectives on its etiology, diagnosis, and treatment. Clin Exp Pediatr. 2024;67(2):80\u20139. https:\/\/doi.org\/10.3345\/cep.2022.01452.","journal-title":"Clin Exp Pediatr"},{"key":"12495_CR10","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.2147\/jir.S413161","volume":"16","author":"Y Luo","year":"2023","unstructured":"Luo Y, Wang Y. Risk prediction model for necrotizing pneumonia in children with Mycoplasma pneumoniae pneumonia. J Inflamm Res. 2023;16:2079\u201387. https:\/\/doi.org\/10.2147\/jir.S413161.","journal-title":"J Inflamm Res"},{"issue":"2","key":"12495_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40121-023-00914-x","volume":"13","author":"X Zhang","year":"2024","unstructured":"Zhang X, Sun RY, Jia WY, Li P, Song CL. Clinical characteristics of lung consolidation with Mycoplasma pneumoniae pneumonia and risk factors for Mycoplasma pneumoniae necrotizing pneumonia in children. Infect Dis Ther. 2024;13(2):329\u201343. https:\/\/doi.org\/10.1007\/s40121-023-00914-x.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"12495_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13052-025-02006-7","volume":"51","author":"X Li","year":"2025","unstructured":"Li X, Zhao L, Cui X, et al. Development and validation of a nomogram for predicting necrotizing pneumonia in children with refractory Mycoplasma pneumoniae pneumonia. Ital J Pediatr. 2025;51(1):150. https:\/\/doi.org\/10.1186\/s13052-025-02006-7.","journal-title":"Ital J Pediatr"},{"issue":"09","key":"12495_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.13604\/j.cnki.46-1064\/r.2024.09.18","volume":"24","author":"W Li","year":"2024","unstructured":"Li W, Jiang JW, Fu S, et al. Clinical characteristics and pathogen profile of 133 cases of community-acquired necrotizing pneumonia in children. China Trop Med. 2024;24(09):1123\u20138. https:\/\/doi.org\/10.13604\/j.cnki.46-1064\/r.2024.09.18.","journal-title":"China Trop Med"},{"issue":"22","key":"12495_CR14","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.12998\/wjcc.v12.i22.4940","volume":"12","author":"LP Wang","year":"2024","unstructured":"Wang LP, Hu ZH, Jiang JS, Jin J. Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity. World J Clin Cases. 2024;12(22):4940\u20136. https:\/\/doi.org\/10.12998\/wjcc.v12.i22.4940.","journal-title":"World J Clin Cases"},{"key":"12495_CR15","doi-asserted-by":"publisher","first-page":"107480","DOI":"10.1016\/j.rmed.2023.107480","volume":"221","author":"X Huang","year":"2024","unstructured":"Huang X, Gu H, Wu R, et al. Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes. Respir Med. 2024;221:107480. https:\/\/doi.org\/10.1016\/j.rmed.2023.107480.","journal-title":"Respir Med"},{"issue":"11","key":"12495_CR16","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.21037\/tp-24-293","volume":"13","author":"F Liu","year":"2024","unstructured":"Liu F, Chen L, Wang MY, et al. Exploring high-risk factors for the prediction of severe Mycoplasma pneumonia in children. Transl Pediatr. 2024;13(11):2003\u201311. https:\/\/doi.org\/10.21037\/tp-24-293.","journal-title":"Transl Pediatr"},{"issue":"1","key":"12495_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12931-020-01577-9","volume":"22","author":"J Wen","year":"2021","unstructured":"Wen J, Su Y, Sun H, Zhang H, Li H. The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study. Respir Res. 2021;22(1):89. https:\/\/doi.org\/10.1186\/s12931-020-01577-9.","journal-title":"Respir Res"},{"key":"12495_CR18","doi-asserted-by":"publisher","first-page":"1094118","DOI":"10.3389\/fped.2023.1094118","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang S, Jiang Z, Li X, et al. Diagnostic value of serum LDH in children with refractory Mycoplasma pneumoniae pneumoniae: A systematic review and meta-analysis. Front Pediatr. 2023;11:1094118. https:\/\/doi.org\/10.3389\/fped.2023.1094118.","journal-title":"Front Pediatr"},{"issue":"1","key":"12495_CR19","doi-asserted-by":"publisher","first-page":"9803","DOI":"10.1038\/s41598-024-60359-1","volume":"14","author":"YH Ren","year":"2024","unstructured":"Ren YH, Zhang ZS, Chen D, Sun XM. Predictive value of lactate dehydrogenase for Mycoplasma pneumoniae necrotizing pneumonia in children based on decision curve analysis and dose-response analysis. Sci Rep. 2024;14(1):9803. https:\/\/doi.org\/10.1038\/s41598-024-60359-1.","journal-title":"Sci Rep"},{"issue":"1","key":"12495_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12931-024-02892-1","volume":"25","author":"YW Wei","year":"2024","unstructured":"Wei YW, Zhang ZY, Zhang TQ, et al. The role of LDH and ferritin levels as biomarkers for corticosteroid dosage in children with refractory Mycoplasma pneumoniae pneumonia. Respir Res. 2024;25(1):266. https:\/\/doi.org\/10.1186\/s12931-024-02892-1.","journal-title":"Respir Res"},{"issue":"7","key":"12495_CR21","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s00431-024-05519-1","volume":"183","author":"G Ding","year":"2024","unstructured":"Ding G, Zhang X, Vinturache A, van Rossum AMC, Yin Y, Zhang Y. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Eur J Pediatr. 2024;183(7):3001\u201311. https:\/\/doi.org\/10.1007\/s00431-024-05519-1.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"12495_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12879-017-2500-z","volume":"17","author":"IA Yoon","year":"2017","unstructured":"Yoon IA, Hong KB, Lee HJ, et al. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2017;17(1):402. https:\/\/doi.org\/10.1186\/s12879-017-2500-z.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"12495_CR23","doi-asserted-by":"publisher","first-page":"e70080","DOI":"10.1002\/rcr2.70080","volume":"12","author":"QK Tran-Le","year":"2024","unstructured":"Tran-Le QK, Vu-Hoai N, Nguyen-Ho L, Duong-Minh N, Nguyen-Thi P. Necrotizing pneumonia-a rare but complex complication in bronchiectasis patients. Respirol Case Rep. 2024;12(12):e70080. https:\/\/doi.org\/10.1002\/rcr2.70080.","journal-title":"Respirol Case Rep"},{"issue":"1","key":"12495_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12879-020-05700-5","volume":"21","author":"X Huang","year":"2021","unstructured":"Huang X, Li D, Liu F, et al. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2021;21(1):14. https:\/\/doi.org\/10.1186\/s12879-020-05700-5.","journal-title":"BMC Infect Dis"},{"issue":"15","key":"12495_CR25","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1002\/cam4.3086","volume":"9","author":"J Zhou","year":"2020","unstructured":"Zhou J, He Z, Ma S, Liu R. AST\/ALT ratio as a significant predictor of the incidence risk of prostate cancer. Cancer Med. 2020;9(15):5672\u20137. https:\/\/doi.org\/10.1002\/cam4.3086.","journal-title":"Cancer Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12495-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12495-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12495-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:35:31Z","timestamp":1770042931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12495-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12495"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12495-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants; if the participants were under 18 years of age, consent was obtained from a parent and\/or legal guardian. This study was approved by the National Children\u2019s Regional Medical Center, Henan Children\u2019s Medical Center, and Henan Pediatric Disease Clinical Medical Research Center (ethical approval No: 2024-K-028).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the study findings have been presented at any conference previously. This research is not part of a PhD thesis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conference presentation"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}